When a critical medication that protects Australia’s most vulnerable communities runs short, who pays the price? A new investigation reveals the shocking gaps in our pharmaceutical sovereignty. By Simran Gill. In late February, Australia faced a crisis that few noticed but many felt: a serious shortage of benzathine benzylpenicillin G (BPG), an essential medication used…
By Peter Coomber, The University of Queensland and Lisa Nissen, The University of Queensland About 400 medicines are in short supply in Australia. Of these, about 30 are categorised as critical. These are ones with a life-threatening or serious impact on patients, and with no readily available substitutes. Since 2024, there has been a nationwide…
Healthcare manufacturer Viatris Australia has announced the Australian Made, Australian Grown (AMAG) logo has now been added to 50 of its Australian medicine products. In what the company describes as a first for a prescription medicine manufacturer in Australia, 50 products manufactured in Carole Park, Queensland, now showcase the logo. Products bearing the AMAG logo…